HCG18 can also act as an oncogene in lung adenocarcinoma by enhancing HMMR expression and can accelerate nasopharyngeal carcinoma progression by upregulating CCND1 (Li et al., 2019; Li et al., 2020a). This evidence concerns the gene HCG18 and lung adenocarcinoma.